Meijers JC - Search Results

1

Ethyl pyruvate exerts combined anti-inflammatory and anticoagulant effects on human monocytic cells.

van Zoelen MA, Bakhtiari K, Dessing MC, van't Veer C, Spek CA, Tanck M, Meijers JC, van der Poll T. van Zoelen MA, et al. Among authors: meijers jc. Thromb Haemost. 2006 Dec;96(6):789-93. Thromb Haemost. 2006. PMID: 17139374

2

Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa.

Hackeng TM, van 't Veer C, Meijers JC, Bouma BN. Hackeng TM, et al. Among authors: meijers jc. J Biol Chem. 1994 Aug 19;269(33):21051-8. J Biol Chem. 1994. PMID: 8063724 Free article.

3

Protein S binding to human endothelial cells is required for expression of cofactor activity for activated protein C.

Hackeng TM, Hessing M, van 't Veer C, Meijer-Huizinga F, Meijers JC, de Groot PG, van Mourik JA, Bouma BN. Hackeng TM, et al. Among authors: meijers jc. J Biol Chem. 1993 Feb 25;268(6):3993-4000. J Biol Chem. 1993. PMID: 8440691 Free article.

4

Effect of heparin on the activation of factor XI by fibrin-bound thrombin.

von dem Borne PA, Meijers JC, Bouma BN. von dem Borne PA, et al. Among authors: meijers jc. Thromb Haemost. 1996 Sep;76(3):347-53. Thromb Haemost. 1996. PMID: 8883269

5

The interaction of protein S with the phospholipid surface is essential for the activated protein C-independent activity of protein S.

van Wijnen M, Stam JG, van't Veer C, Meijers JC, Reitsma PH, Bertina RM, Bouma BN. van Wijnen M, et al. Among authors: meijers jc. Thromb Haemost. 1996 Sep;76(3):397-403. Thromb Haemost. 1996. PMID: 8883277

6

Plasma TAFI levels influence the clot lysis time in healthy individuals in the presence of an intact intrinsic pathway of coagulation.

Mosnier LO, von dem Borne PA, Meijers JC, Bouma BN. Mosnier LO, et al. Among authors: meijers jc. Thromb Haemost. 1998 Nov;80(5):829-35. Thromb Haemost. 1998. PMID: 9843179

7

A plasma coagulation assay for an activated protein C-independent anticoagulant activity of protein S.

van Wijnen M, van 't Veer C, Meijers JC, Bertina RM, Bouma BN. van Wijnen M, et al. Among authors: meijers jc. Thromb Haemost. 1998 Dec;80(6):930-5. Thromb Haemost. 1998. PMID: 9869163

8

Characterization of transgenic mice that secrete functional human protein C inhibitor into the circulation.

Wagenaar GT, van Vuuren AJ, Girma M, Tiekstra MJ, Kwast L, Koster JG, Rijneveld AW, Elisen MG, van der Poll T, Meijers JC. Wagenaar GT, et al. Among authors: meijers jc. Thromb Haemost. 2000 Jan;83(1):93-101. Thromb Haemost. 2000. PMID: 10669161

9

Characterization of mouse thrombin-activatable fibrinolysis inhibitor.

Marx PF, Wagenaar GT, Reijerkerk A, Tiekstra MJ, van Rossum AG, Gebbink MF, Meijers JC. Marx PF, et al. Among authors: meijers jc. Thromb Haemost. 2000 Feb;83(2):297-303. Thromb Haemost. 2000. PMID: 10739389

10

Effects on coagulation of levonorgestrel- and desogestrel-containing low dose oral contraceptives: a cross-over study.

Middeldorp S, Meijers JC, van den Ende AE, van Enk A, Bouma BN, Tans G, Rosing J, Prins MH, Büller HR. Middeldorp S, et al. Among authors: meijers jc. Thromb Haemost. 2000 Jul;84(1):4-8. Thromb Haemost. 2000. PMID: 10928461 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

436 results

Search Page

Filters